Imagion Biosystems

Imagion Biosystems EBIT Margin

The EBIT Margin (Operating Margin) of Imagion Biosystems (IBX.AX) as of Oct 18, 2026 is -10,920.33 %. In the previous year, EBIT Margin (Operating Margin) was -28.39 % — a change of 38,369.43% (lower).

EBIT Margin

-10,920.33 %

YoY

38,369.43%

Last updated:

EBIT Margin (Operating Margin) of Imagion Biosystems is 2025 -10,920.33 % . EBIT Margin (Operating Margin) of Imagion Biosystems was 2024 -28.39 % . It decreases by 38,369.43% lower compared to the previous year.

For Imagion Biosystems, the operating (EBIT) margin of -10,920.3% is down versus -3,570.5% a few years ago.

The Imagion Biosystems EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-4,351.57 AUD
Jan 1, 2019
-833.23 AUD
Jan 1, 2020
-3,771.72 AUD
Jan 1, 2021
-3,570.53 AUD
Jan 1, 2022
-2,562.97 AUD
Jan 1, 2023
-1,380.43 AUD
Jan 1, 2024
-28.39 AUD
Jan 1, 2025
-10,920.33 AUD
The Imagion Biosystems EBIT Margin history
YEAREBIT MarginYoY
-10,920.33 %+38,369.43%
-28.39 %-97.94%
-1,380.43 %-46.14%
-2,562.97 %-28.22%
-3,570.53 %-5.33%
-3,771.72 %+352.66%
-833.23 %-80.85%
-4,351.57 %-87.25%
-34,122.66 %-99.28%
-4.72 M %+6,186.84%
-75,099.99 %+97.84%
-37,959.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Imagion Biosystems Stock analysis

What does Imagion Biosystems do? Imagion Biosystems Ltd is a Melbourne-based company operating in the Health Care sector. It focuses on research and development of non-radioactive diagnostic imaging technology. The company went public on June 22, 2017. Its MagSense technology uses bio-safe magnetic nanoparticles for cancer detection, specifically formulated for breast, prostate, and ovarian cancers. MagSense nanoparticles are injectable solutions tailored to each cancer type. The firm also develops PrecisionMRX nanoparticles for magnetic relaxometry, available in various coatings including dextran, mPEG, oleic acid, and carboxylic acid functionalized. Imagion Biosystems operates through a Research and Development segment. Imagion Biosystems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imagion Biosystems stock

EBIT Margin (Operating Margin) of Imagion Biosystems is -10,920.33 % in 2025.

EBIT Margin (Operating Margin) of Imagion Biosystems changed from -28.39 % to -10,920.33 %, representing a 38,369.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Imagion Biosystems since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Imagion Biosystems with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Imagion Biosystems

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Imagion Biosystems